Both are developed by the Institute of Molecular Genetics (Russia) and approved in Russia
Vergara, M., Smith-Wheelock, M., Harper, J
This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market
Nutritional ketosis for weight management and reversal of metabolic syndrome
This paper provides a review on the current evidence supporting the use of GLP-1 in experimental animal models and human trials with the ischemic and non-ischemic heart and discusses their molecular mechanisms and potential as a new therapeutic approach
GLP-1 receptor agonists have revolutionized medical weight loss, but they often come with side effects like nausea and appetite suppression, and can lead to nutrient deficiencies